FDA issued a Warning Letter to Delta Pharma, Inc. on 12/9/2014 as a result of this inspection.
FDA investigators audited the Delta Pharma - Ripley, MS, United States facility and issued 9 inspectional observations (via FDA 483) on 02 Oct 2013.
Add To Cart
- Category: Human Drugs
- Number of Observations: 9
- Inspection end: 02 Oct 2013
- Location: Ripley, United States
- FEI: 3004034796